NCT04555278 Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain Status COMPLETED Phase NA
NCT04553133 PF-07104091 as a Single Agent and in Combination Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04552470 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT04550936 A Study to Understand How the Use of Paxlovid Affected the Healthcare Use in People With Pre-existing Conditions. Status COMPLETED Phase N/A
NCT04549480 Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition Status COMPLETED Phase PHASE1
NCT04546425 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants Status COMPLETED Phase PHASE3
NCT04543357 A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts. Status TERMINATED Phase N/A
NCT04543344 Study To Evaluate The Pharmacokinetic, Safety And Tolerability Of Single Or Multiple Subcutaneous Doses of Recifercept Status COMPLETED Phase PHASE1
NCT04543188 A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement Status TERMINATED Phase PHASE1
NCT04541706 Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India Status COMPLETED Phase PHASE4
NCT04535349 Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis Status RECRUITING Phase NA
NCT04535167 First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. Status COMPLETED Phase PHASE1
NCT04530838 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants Status COMPLETED Phase PHASE3
NCT04526574 Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age Status COMPLETED Phase PHASE3
NCT04517864 PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA Status TERMINATED Phase PHASE2
NCT04517669 Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice Status COMPLETED Phase N/A
NCT04511533 Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations Status COMPLETED Phase PHASE4